Application of LC-MS/MS Method for Evaluating Rosuvastatin Affinity with OATP1B1 and OATP2B1 in vitro

被引:1
|
作者
Zhang, Zhi-Yu [1 ,2 ]
Li, Quan-Sheng [2 ]
Si, Duan-Yun [2 ]
Yi, Xiu-Lin [2 ]
Liu, Chang-Xiao [2 ]
机构
[1] Tianjin Univ, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China
[2] Tianjin Inst Pharmaceut Res, State Key Lab Drug Delivery Technol & Pharmacokin, Tianjin 300193, Peoples R China
关键词
LC/MS/MS; Transporter; Rosuvastatin; OATP1B1; OATP2B1; HUMAN PLASMA; MASS-SPECTROMETRY; LIQUID-CHROMATOGRAPHY; HEPATIC-UPTAKE; TRANSPORTERS; QUANTIFICATION; DRUG; PHARMACOKINETICS; ACID; HPLC;
D O I
10.14233/ajchem.2014.15376
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Drug-drug interaction is one of the Most important preclinical investigation directions, It may have serious impact on drug absorption, distribution and elimination through Membrane transporters, Liquid chromatography/Tandem Mass spectrometry (LC/MS/MS) Could be used to investigate drug drug interaction in vitro. A sensitive LC/MS/MS method was established for quantification of rosuvastatin in HEK293 and S2 cell lysates. Internal standard (IS) was indapamide. Detection mode was positive eleetrospray ionization. The lower limit of quantification (LLOQ) was 0.05 ng/mL. The affinity of rosuvastatin with organic anion transporting polypeptides 1B1 and 2B1 (OATP1B1 and OATP2B1) was investigated through uptake experiment, All cell samples were precipitated with methanol. Analytes were separated by reversed-phase chromatography and analyze by Tandem mass spectrometry using m/z 482.2/258.1 for rosuvastatin and m/z 366.1/132.1 for indapamide. Rosuvastatin uptake was saturable with KM value of 11.70 and 5.98 mu M for OATP1B1 and OATP2B1. Rosuvastatin could be used as a good probe for studying membrane transporter activity and drug-drug interaction through LC/MS/MS method.
引用
收藏
页码:335 / 341
页数:7
相关论文
共 50 条
  • [31] Dissecting the Contribution of OATP1B1 to Hepatic Uptake of Statins Using the OATP1B1 Selective Inhibitor Estropipate
    Zhang, Yueping
    Panfen, Erika
    Fancher, Marcus
    Sinz, Michael
    Marathe, Punit
    Shen, Hong
    MOLECULAR PHARMACEUTICS, 2019, 16 (06) : 2342 - 2353
  • [32] FUNCTIONAL ASSESSMENT OF OATP1B1 AND BCRP POLYMORPHISMS IN AN OATP1B1/BCRP CO-EXPRESSING MODEL
    Warren, Mark
    Jahic, Mirza
    Zhang, Xuexiang
    Kaufman, Ilene
    Huang, Jane
    Huang, Yong
    DRUG METABOLISM REVIEWS, 2014, 45 : 246 - 247
  • [33] Human OATP1B1, OATP1B3 and OATP1A2 can mediate the in vivo uptake and clearance of docetaxel
    Iusuf, Dilek
    Hendrikx, Jeroen J. M. A.
    van Esch, Anita
    de Steeg, Evita van
    Wagenaar, Els
    Rosing, Hilde
    Beijnen, Jos H.
    Schinkel, Alfred H.
    INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (01) : 225 - 233
  • [34] Interaction of Sulfonylureas with Liver Uptake Transporters OATP1B1 and OATP1B3
    Chen, Yu
    Chen, Lin
    Zhang, Hong
    Huang, Shibo
    Xiong, Yuqing
    Xia, Chunhua
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 (02) : 147 - 154
  • [35] Digoxin Is Not a Substrate for Organic Anion-Transporting Polypeptide Transporters OATP1A2, OATP1B1, OATP1B3, and OATP2B1 but Is a Substrate for a Sodium-Dependent Transporter Expressed in HEK293 Cells
    Taub, Mitchell E.
    Mease, Kirsten
    Sane, Rucha S.
    Watson, Cory A.
    Chen, Liangfu
    Ellens, Harma
    Hirakawa, Brad
    Reyner, Eric L.
    Jani, Marton
    Lee, Caroline A.
    DRUG METABOLISM AND DISPOSITION, 2011, 39 (11) : 2093 - 2102
  • [36] FUNCTION OF OATP2B1 IN DRUG TRANSPORT
    Grube, Markus
    Koeck, Kathleen
    Oswald, Stefan
    Jedlitschky, Gabriele
    Siegmund, Werner
    Kroemer, Heyo K.
    DRUG METABOLISM REVIEWS, 2007, 39 : 286 - 287
  • [37] Generation of Bayesian prediction models for OATP-mediated drug-drug interactions based on inhibition screen of OATP1B1, OATP1B1*15 and OATP1B3
    van de Steeg, E.
    Venhorst, J.
    Jansen, H. T.
    Nooijen, I. H. G.
    DeGroot, J.
    Wortelboer, H. M.
    Vlaming, M. L. H.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 70 : 29 - 36
  • [38] Effect of clotrimazole on transport mediated by human OATP1B1 and OATP1B3
    Gui, Chunshan
    Thompson, Lucas
    Hagenbuch, Bruno
    HEPATOLOGY, 2006, 44 (04) : 379A - 379A
  • [39] In vitro OATP1B1 and OATP1B3 inhibition is associated with observations of benign clinical unconjugated hyperbilirubinemia
    Chiou, William J.
    de Morais, Sonia M.
    Kikuchi, Ryota
    Voorman, Richard L.
    Li, Xiaofeng
    Bow, Daniel A. J.
    XENOBIOTICA, 2014, 44 (03) : 276 - 282
  • [40] The 2-aminoethyl diphenylborinate-based fluorescent method identifies quercetin and luteolin metabolites as substrates of Organic anion transporting polypeptides, OATP1B1 and OATP2B1
    Kaci, Hana
    Bakos, Eva
    Needs, Paul W.
    Kroon, Paul A.
    Valentova, Katerina
    Poor, Miklos
    Ozvegy-Laczka, Csilla
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 196